Hirotsu Bio Science Expands into US with New Branch in Delaware
Hirotsu Bio Science Enters the US Cancer Screening Market
Hirotsu Bio Science, headquartered in Chiyoda, Tokyo, has made its official entrance into the thriving cancer screening market of the United States by establishing a local subsidiary named Hirotsu Global Inc. This new entity was registered in Delaware on March 6, 2026 (Japan time), laying the groundwork for extensive business operations and research partnerships.
Along with this, Hirotsu has opened a new business hub in the innovation-rich Bay Area of California, marking a significant step towards global expansion.
Unique Technology from Japan in the Largest Market
The US is recognized as the largest cancer screening market in the world, where awareness and investment in preventive healthcare are the highest globally. Leveraging the expertise and accomplishments Hirotsu has built in Japan, the company is ready to take on this enormous market.
Hirotsu Global Inc. is not merely a subsidiary; it aims to serve as the company's
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.